These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27162295)

  • 41. [Bone marrow transplantation for lysosomal storage diseases].
    Imaizumi M
    Nihon Rinsho; 1995 Dec; 53(12):3083-8. PubMed ID: 8577063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy for lysosomal storage disorders.
    Beck M
    IUBMB Life; 2010 Jan; 62(1):33-40. PubMed ID: 20014233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical studies in lysosomal storage diseases: past, present and future.
    Boudes PF
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():68-76. PubMed ID: 24380125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The NCS-LSD cohort study: a description of the methods and analyses used to assess the long-term effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with lysosomal storage disorders.
    Henley WE; Anderson LJ; Wyatt KM; Nikolaou V; Anderson R; Logan S
    J Inherit Metab Dis; 2014 Nov; 37(6):939-44. PubMed ID: 24519353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene therapy for the lysosomal storage disorders.
    Cabrera-Salazar MA; Novelli E; Barranger JA
    Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lysosomal enzymes may cross the blood-brain-barrier by pinocytosis: implications for enzyme replacement therapy.
    Baldo G; Giugliani R; Matte U
    Med Hypotheses; 2014 Apr; 82(4):478-80. PubMed ID: 24560457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Newborn screening for lysosomal storage disorders.
    Nakamura K; Hattori K; Endo F
    Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):63-71. PubMed ID: 21312327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene therapy progress and prospects: gene therapy of lysosomal storage disorders.
    Cheng SH; Smith AE
    Gene Ther; 2003 Aug; 10(16):1275-81. PubMed ID: 12883523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Journey towards Understanding the Molecular Pathology and Developing Therapies for Lysosomal Storage Disorders.
    Tikkanen R
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment for Lsds: real options for several diseases. Forward.
    Cohen IJ; Baris HN; Mistry PK; Sands MS
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():71. PubMed ID: 25345087
    [No Abstract]   [Full Text] [Related]  

  • 52. Current and emerging therapies for the lysosomal storage disorders.
    Pastores GM; Barnett NL
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):891-902. PubMed ID: 16262569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights into the diagnosis and treatment of lysosomal storage diseases.
    Wenger DA; Coppola S; Liu SL
    Arch Neurol; 2003 Mar; 60(3):322-8. PubMed ID: 12633142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene therapy for lysosomal storage disorders.
    Yew NS; Cheng SH
    Curr Opin Mol Ther; 2001 Aug; 3(4):399-406. PubMed ID: 11525564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Musculoskeletal manifestations of lysosomal storage disorders.
    Aldenhoven M; Sakkers RJ; Boelens J; de Koning TJ; Wulffraat NM
    Ann Rheum Dis; 2009 Nov; 68(11):1659-65. PubMed ID: 19822711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mechanism of action of cell therapy in hereditary diseases].
    Martinez-Morga M; Medina-Corvalan C; Pérez-García C; Bueno C; Martinez S
    Medicina (B Aires); 2020; 80 Suppl 2():2-6. PubMed ID: 32150704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Editorial: Genetics and Gene Therapy of Lysosomial Storage Disorders.
    Tuttolomondo A
    Curr Gene Ther; 2018; 18(2):66-67. PubMed ID: 29741137
    [No Abstract]   [Full Text] [Related]  

  • 58. Orphan drug development.
    Pastores GM; Gupta P
    Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():64-7. PubMed ID: 24380124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eighth International Symposium on Lysosomal Storage Diseases.
    Mehta AB; Germain DP; Martin R
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S1-3. PubMed ID: 20040305
    [No Abstract]   [Full Text] [Related]  

  • 60. Bone marrow transplantation therapy for metabolic disease: animal models as predictors of success and in utero approaches.
    Haskins M
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S25-7. PubMed ID: 8971403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.